[Ala11, D-Leu15]-Orexin B (Human)

<strong>[Ala11, D-Leu15]-Orexin B (Human)</strong> <strong>Catalog number:</strong> MDP0836 <strong>CAS Number: </strong>186689-07-6 <strong>Sequence: </strong>Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Ala-Gln-Arg-Leu-D-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 <strong>Amount:</strong> 100 ug <strong>Molecular Weight:</strong> 2857.2 g/mol <strong>Supplied as:</strong> Powder <strong>Applications:</strong> molecular tool for various biochemical applications <strong>Storage:</strong> -20 °C <strong>WARNING:</strong> For in vitro Research Use Only. NOT for use on humans or animals. <strong>Grade:</strong> Biotechnology grade. All products are highly pure. <strong>References:</strong> 1: Asahi S, Egashira S, Matsuda M, Iwaasa H, Kanatani A, Ohkubo M, Ihara M, Morishima H. Development of an orexin-2 receptor selective agonist, [Ala(11), D-Leu(15)]orexin-B Bioorg Med Chem Lett. 2003 Jan 6;13(1):111-3. 2: Li TL, Chen JYS, Huang SC, Dai YE, Hwang LL. Cardiovascular pressor effects of orexins in the dorsomedial hypothalamus Eur J Pharmacol. 2018 Jan 5;818:343-350. 3: Maehara S, Furukawa J, Ota T. Orexin 2 receptor is involved in orexin A-induced hyperlocomotion in rats Pharmacol Rep. 2019 Dec;71(6):1147-1150. 4: Putula J, Turunen PM, Jäntti MH, Ekholm ME, Kukkonen JP. Agonist ligand discrimination by the two orexin receptors depends on the expression system Neurosci Lett. 2011 Apr 20;494(1):57-60. 5: Patel VH, Karteris E, Chen J, Kyrou I, Mattu HS, Dimitriadis GK, Rodrigo G, Antoniades C, Antonopoulos A, Tan BK, Hillhouse EW, Ng A, Randeva HS. Functional cardiac orexin receptors: role of orexin-B/orexin 2 receptor in myocardial protection Clin Sci (Lond). 2018 Dec 13;132(24):2547-2564. 6: Putula J, Turunen PM, Johansson L, Näsman J, Ra R, Korhonen L, Kukkonen JP. Orexin/hypocretin receptor chimaeras reveal structural features important for orexin peptide distinction FEBS Lett. 2011 May 6;585(9):1368-74. 7: Maehara S, Yuge N, Higashi C, Ota T, Furukawa J, Takeuchi T. Pharmacological characterization of a novel potent, selective, and orally active orexin 2 receptor antagonist, SDM-878 Neuropsychopharmacol Rep. 2020 Jun;40(2):182-189. 8: Guerreiro S, Florence C, Rousseau E, Hamadat S, Hirsch EC, Michel PP. The sleep-modulating peptide orexin-B protects midbrain dopamine neurons from degeneration, alone or in cooperation with nicotine Mol Pharmacol. 2015;87(3):525-32. 9: Lee HJ, Chang LY, Ho YC, Teng SF, Hwang LL, Mackie K, Chiou LC. Stress induces analgesia via orexin 1 receptor-initiated endocannabinoid/CB1 signaling in the mouse periaqueductal gray Neuropharmacology. 2016 Jun;105:577-586. <a href="https://pubmed.ncbi.nlm.nih.gov/19751316">10: Malherbe P, Borroni E, Gobbi L, Knust H, Nettekoven M, Pinard E, Roche O, Rogers-Evans M, Wettstein JG, Moreau JL. Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor Br J Pharmacol. 2009 Apr;156(8):1326-41. </a> <br><strong>Products Related to [Ala11, D-Leu15]-Orexin B (Human) can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>